Luoma, Sini http://orcid.org/0000-0002-1194-7027
Anttila, Pekka
Säily, Marjaana
Lundan, Tuija
Heiskanen, Jouni
Siitonen, Timo
Kakko, Sakari
Putkonen, Mervi
Ollikainen, Hanna
Terävä, Venla
Sankelo, Marja
Partanen, Anu
Launonen, Kirsi
Räsänen, Anu
Sikiö, Anu
Suominen, Merja
Bazia, Piotr
Kananen, Kristiina
Lievonen, Juha
Selander, Tuomas
Pelliniemi, Tarja-Terttu
Ilveskero, Sorella
Huotari, Virva
Mäntymaa, Pentti
Tienhaara, Anri
Jantunen, Esa
Silvennoinen, Raija
Funding for this research was provided by:
Celgene
Research Committee of the Kuopio University Hospital catchment area (5101424)
Helsinki University Hospital Comprehensive Cancer Center (Y1018XPA01)
Article History
Received: 17 December 2018
Accepted: 8 October 2019
First Online: 31 October 2019
Compliance with ethical standards
:
: SL has been a lecturer for Amgen and received educational travel grants from Abbvie and Amgen. RS has received research funding from Celgene, Amgen, BMS, and Takeda, and has been a consultant and lecturer for Celgene, Amgen, BMS, Takeda, and Genzyme/Sanofi. EJ reports honoraria from Genzyme/Sanofi and Amgen and has participated in Advisory Boards of Amgen, Takeda, and TEVA. MP has received Advisory Board honoraria from Amgen, Celgene, and Takeda. AR has participated in Advisory Boards organized by Amgen and Roche and received educational travel grants from Gilead, Pfizer, and Roche. TiS has participated in Advisory Boards of Roche and Amgen, has been a lecturer for Amgen and Celgene, and received educational travel grants from Novartis, Pfizer, Gilead, and Amgen. JL has received educational travel grants from Janssen-Cilag, Celgene, Amgen, Novartis, TEVA, Takeda, and Roche, and has been a consultant for Celgene, Amgen, and Novartis. KK has received honoraria from Amgen, Roche, and Fresenius. VT has participated in Advisory Board organized by Amgen and received an educational travel grant from Celgene. JH has received an educational travel grant from and been a lecturer for Sanofi. MaS has received educational travel grants from Celgene, Genzyme, and Pfizer. KL has received educational travel grants from Celgene, Mundipharma, and Novartis. AP reports honoraria from Behring and has participated Medical Advisory Board meeting organized by Abbvie. HO has received educational travel grants from Celgene, Genzyme, and Gilead. The remaining authors declare no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.